(Via e-mail)
VANCOUVER, Canada, August 26th, 2011 - Finavera Wind Energy Inc. ("Finavera" or the "Company")(TSX-V: FVR) announces the Environmental Assessment Office ("EAO") has requested additional information be provided for the Company's Wildmare and Tumbler Ridge Wind Energy Project Environmental Assessment Applications. In order to provide appropriate time for the EAO to assess the additional information, the 180 day Application Review period will be put on hold until the information is submitted.
Finavera Wind Energy President and COO Peter Leighton said, "With two projects moving through the approval process simultaneously there is a tremendous amount of assessment review work to be carried out by the EAO and this will allow a full and complete assessment to be concluded. It is important to note this does not restart the 180 Application Review Periods and the delay will only be in place until the additional information is provided to the EAO. We look forward to working with the EAO to provide the required information in a timely manner."
The Company does not anticipate this additional process will take more than one month, and it still provides the required time for the Projects to meet financial close and move to construction on time in early 2012.
The Company would also like to update the status of the projects with regard to the Federal Environmental Assessment process. The federal environmental assessment process is applied whenever a federal authority has a specified decision-making responsibility in relation to a project, also known as a "trigger" for an environmental assessment. Finavera has received confirmation from the relevant federal authorities that a federal trigger does not exist for either the Wildmare or Tumbler Ridge Wind Energy Projects, and as such, federal environmental assessments are not required.
Jason Bak, CEO
For more information:
Finavera Renewables
Myke Clark
SVP Business Development
Finavera Renewables
(604)-288-9051
mclark@finavera.com
Investor Relations
Pinnacle Capital Markets
Spyros Karellas
(416) 800-8921
(416) 433-5696
spyros@pinnaclecapitalmarkets.ca
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM